Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 7/20 | 0.44 |
| ▸ | DRD3 | P35462 | 4/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 2/20 | 0.40 |
| ▸ | DRD4 | P21917 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HTR5A | P47898 | 1/20 | 0.36 |
| ▸ | DRD1 | P21728 | 1/20 | 0.36 |
| ▸ | DRD5 | P21918 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL659339 | 0.83 | LMNA (0.45) | DRD2DRD3CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL659340 | 0.83 | LMNA (0.45) | DRD2DRD3CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL26962585 | 0.74 | CYP19A1 (0.37) | DRD2DRD3CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL20205680 | 0.73 | SRD5A1 (0.41) | DRD2DRD3HTR5A | |
| SCHEMBL266254 | 0.73 | KDM4E (0.56) | CYP19A1CYP11B1CYP11B2ALDH1A1 | |
| SCHEMBL28463150 | 0.73 | CYP19A1 (0.46) | DRD2DRD3CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL20205516 | 0.72 | DRD2 (0.44) | DRD2DRD3CYP19A1DRD4MAPT | |
| SCHEMBL23678246 | 0.71 | MAPT (0.57) | MAPTRAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL20205671 | 0.71 | MAPT (0.57) | MAPTRAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL19133719 | 0.67 | DRD2 (0.58) | DRD2DRD3DRD4CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11225470-B2 | Tetrazolinone compounds and its use as pest control agents | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-01-18 | — | — | US | disclosed |
| EP-3544973-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PEST CONTROL AGENTS | SUMITOMO CHEMICAL CO (JP) | 2021-07-28 | — | — | EP | disclosed |
| WO-2018097318-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PEST CONTROL AGENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11225470-B2 | Tetrazolinone compounds and its use as pest control agents | CYC1, MT-CO1, CTRL | DRD2 2135/4885DRD3 1146/4885CYP19A1 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.